Isoniazid-resistant Tuberculosis in Children: A Systematic Review

Pediatric Infectious Disease Journal

Volumn 32, Issue 5, 2013, Pages e217-e226

  Yuen, Courtney M ^a   Tolman, Arielle W ^a   Cohen, Ted ^a   Parr, Jonathan B ^a   Keshavjee, Salmaan ^a   Becerra, Mercedes C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Drug resistance; Isoniazid; Latent tuberculosis infection; Monoresistance; Pediatric

Indexed keywords

ISONIAZID;

BIBLIOGRAPHIC DATABASE; CHILDHOOD DISEASE; DISEASE PREDISPOSITION; EMBASE; HUMAN; ISONIAZID RESISTANT TUBERCULOSIS; LILAC; MEDLINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS;

EID: 84879092256     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182865409     Document Type: Review

References (123)

1. Jenkins HE, Zignol M, Cohen T. Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009. PLoS ONE. 2011;6:e22927
2. Bloch AB, Snider DE Jr. How much tuberculosis in children must we accept? Am J Public Health. 1986;76:14-15
3. Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis. 2003;3:624-632
4. Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000146
5. Menzies D, Benedetti A, Paydar A, et al. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000150
6. Lew W, Pai M, Oxlade O, et al. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008;149:123-134
7. Ahmad S. New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res. 2010;11:169
8. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-51
9. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. 2006 Geneva World Health Organization
10. Sneag DB, Schaaf HS, Cotton MF, et al. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J. 2007;26:1142-1146
11. Tochon M, Bosdure E, Salles M, et al. Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis. 2011;15:326-330
12. Grosset J, Benhassine M. Antibiotic primary resistance of mycobacterium tuberculosis in hospitals in Algeria (1964-1966). Rev Tuberc Pneumol (Paris). 1967;31:475-490
13. Stauffer F, Makristathis A, Klein JP, et al. Drug resistance rates of Mycobacterium tuberculosis strains in Austria between 1995 and 1998 and molecular typing of multidrug-resistant isolates. The Austrian Drug Resistant Tuberculosis Study Group. Epidemiol Infect. 2000;124:523-528
14. Van Deun A, Salim AH, Daru P, et al. Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis. 2004;8:23-30
15. Bajraktarevic A, Mulalic Z, Perva N, et al. Tuberculosis in Bosnian children as result of endemic situation, refugees and migration. Trop Med Int Health. 2009;14:231
16. Silveira J, Medeiros S. Primary resistance in childhood. Correlation of infectious source with those exposed to infection. Torax. 1971;20:113-116
17. Ferrazoli L, Palaci M, Marques LR, et al. Transmission of tuberculosis in an endemic urban setting in Brazil. Int J Tuberc Lung Dis. 2000;4:18-25
18. Telles MA, Ferrazoli L, Waldman EA, et al. A population-based study of drug resistance and transmission of tuberculosis in an urban community. Int J Tuberc Lung Dis. 2005;9:970-976
19. Brito RC, Mello FC, Andrade MK, et al. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010;14:24-33
20. Sanders M, Van Deun A, Ntakirutimana D, et al. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey. Int J Tuberc Lung Dis. 2006;10:178-183
21. Farzad E, Holton D, Long R, et al. Drug resistance study of Mycobacterium tuberculosis in Canada, February 1, 1993 to January 31, 1994. Can J Public Health. 2000;91:366-370
22. Kassa-Kelembho E, Bobossi-Serengbe G, Takeng EC, et al. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis. 2004;8:574-578
23. Shen X, Shen M, Gui XH, et al. The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30:407-410
24. Llerena C, Fadul SE, Garzón MC, et al. Drug-resistant Mycobacterium tuberculosis in children under 15 years. Biomedica. 2010;30:362-370
25. Elenga N, Kouakoussui KA, Bonard D, et al. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d’Ivoire: ANRS 1278 study. Pediatr Infect Dis J. 2005;24:1077-1082
26. Thomsen VO, Bauer J, Lillebaek T, et al. Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Eur Respir J. 2000;16:203-208
27. Christensen AS, Andersen AB, Thomsen VO, et al. Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect Dis. 2011;11:47
28. Espinal MA, Báez J, Soriano G, et al. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int J Tuberc Lung Dis. 1998;2:490-498
29. Morcos W, Morcos M, Doss S, et al. Drug-resistant tuberculosis in Egyptian children using Etest. Minerva Pediatr. 2008;60:1385-1392
30. Tudó G, González J, Obama R, et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis. 2004;8:15-22
31. Ejigu GS, Woldeamanuel Y, Shah NS, et al. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008;12:332-337
32. Aho K, Hallstrom K, Wager O. Incidence of primarily resistant tubercle bacilli in Finland. Difference in child and adult series. Acta Tuberc Pneumol Scand. 1962;42:214-221
33. Aho K, Brander E, Pätiälä J. Studies of primary drug resistance in tuberculous pleurisy. Scand J Respir Dis Suppl. 1968;63:111-114
34. Breton A, Gaudier B, Pierret R. Incidence of resistance of Koch bacillus to antibiotics during primary infection. Arch Fr Pediatr. 1956;13:664-674
35. Kaplan M, Dobrowolski B. Study of the germs isolated from 289 cases of initial tuberculosis in children. Frequenc of isolation. Cultural and biological characteristics. Resistance to antibiotics. Arch Fr Pediatr. 1960;17:605-626
36. Brudey K, Filliol I, Ferdinand S, et al. Long-term population-based genotyping study of Mycobacterium tuberculosis complex isolates in the French departments of the Americas. J Clin Microbiol. 2006;44:183-191
37. Kessler R, Bartmann K. Primary isoniazid resistance in tuberculous children of West Berlin. Pneumonologie. 1971;145:400-406
38. Forssbohm M, Loddenkemper R, Rieder HL. Isoniazid resistance among tuberculosis patients by birth cohort in Germany. Int J Tuberc Lung Dis. 2003;7:973-979
39. Haas WH, Altmann D, Brodhun B. Epidemiology of tuberculosis in childhood. Monatsschr Kinderh. 2006;154:118-123
40. Gitti Z, Mantadakis E, Maraki S, et al. GenoType(R) MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale. Future Microbiol. 2011;6:357-362
41. Scalcini M, Carré G, Jean-Baptiste M, et al. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis. 1990;142:508-511
42. Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Int J Tuberc Lung Dis. 2001;5:815-823
43. Swaminathan S, Datta M, Radhamani MP, et al. A profile of bacteriologically confirmed pulmonary tuberculosis in children. Indian Pediatr. 2008;45:743-747
44. Kumar A, Upadhyay S, Kumari G. Clinical Presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. Curr HIV Res. 2007;5:499-504
45. Joseph MR, Shoby CT, Amma GR, et al. Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis. 2007;11:443-449
46. Aparna SB, Reddy VC, Gokhale S, et al. in vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India. Trans R Soc Trop Med Hyg. 2009;103:564-570
47. Baveja CP, Gumma V, Jaint M, et al. Multi drug resistant tuberculous meningitis in pediatric age group. Iran J Pediatr. 2008;18:309-314
48. Agashe V, Shenai S, Mohrir G, et al. Osteoarticular tuberculosis-diagnostic solutions in a disease endemic region. J Infect Dev Ctries. 2009;3:511-516
49. Vadwai V, Boehme C, Nabeta P, et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol. 2011;49:2540-2545
50. Romano A, Di Carlo P, Abbagnato L, et al. Pulmonary tuberculosis in Italian children by age at presentation. Minerva Pediatr. 2004;56:189-195
51. Osato T, Kihara K, Iwasaki T, et al. Studies on infection by drug-resistant tubercle bacilli. 2. Primary drug resistance in children. Kekkaku. 1968;43:431-436
52. Tuberculosis Research Committee (Ryoken). Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002. Int J Tuberc Lung Dis. 2007;11:1129-1135
53. East African and British Medical Research Council. Tuberculosis in Kenya: a national sampling survey of drug resistance and other factors. Tubercle. 1968;49:136-169
54. East African and British Medical Research Council. Tuberculosis in Kenya 1984: a third national survey and a comparison with earlier surveys in 1964 and 1974. A Kenyan/British Medical Research Council Co-operative Investigation. Tubercle. 1989;70:5-20
55. Githui WA, Juma ES, Van Gorkom J, et al. Antituburculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis. 1998;2:499-505
56. Araj GF, Itani LY, Kanj NA, et al. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995. J Med Liban. 2000;48:18-22
57. Rasolofo Razanamparany V, Ramarokoto H, Clouzeau J, et al. Tuberculosis in children less than 11 years old: primary resistance and dominant genetic variants of Mycobacterium tuberculosis in Antananarivo. Arch Inst Pasteur Madagascar. 2002;68:41-43
58. Ramarokoto H, Ratsirahonana O, Soares JL, et al. First national survey of Mycobacterium tuberculosis drug resistance, Madagascar, 2005-2006. Int J Tuberc Lung Dis. 2010;14:745-750
59. Warndorff DK, Yates M, Ngwira B, et al. Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis. 2000;4:752-757
60. Yang ZH, Rendon A, Flores A, et al. A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico. Int J Tuberc Lung Dis. 2001;5:313-320
61. Amaya-Tapia G, Martín-Del Campo L, Aguirre-Avalos G, et al. Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico. Microb Drug Resist. 2000;6:143-145
62. Zazueta-Beltran J, León-Sicairos N, Muro-Amador S, et al. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. Int J Infect Dis. 2011;15:e272-e276
63. Buyankhishig B, Naranbat N, Mitarai S, et al. Nationwide survey of anti-tuberculosis drug resistance in Mongolia. Int J Tuberc Lung Dis. 2011;15:1201-1205 i
64. Chaoui I, Sabouni R, Kourout M, et al. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries. 2009;3:278-284
65. Das D, Baker M, Venugopal K, et al. Why the tuberculosis incidence rate is not falling in New Zealand. N Z Med J. 2006;119:U2248
66. Krogh K, Surén P, Mengshoel AT, et al. Tuberculosis among children in Oslo, Norway, from 1998 to 2009. Scand J Infect Dis. 2010;42:866-872
67. Bujko K, Zapasnik-Kobierska MH, Maliszewska Z, et al. Primary resistance to basic antituberculous drugs in tuberculosis in children. Pol Med Sci Hist Bull. 1966;9:81-85
68. Zwolska Z, Augustynowicz-Kopec E, Klatt M. Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme. Int J Tuberc Lung Dis. 2000;4:832-838
69. st century. Rev Port Pneumol. 2009;15:771-782
70. Al-Marri MR. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Int J Tuberc Lung Dis. 2001;5:1116-1121
71. Kim SJ, Bai GH, Hong YP. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis. 1997;1:302-308
72. Rudoi NM, Rachinskii SV. Drug resistance of mycobacterium tuberculosis in young children. Probl Tuberk. 1963;41:41-45
73. Alrajhi AA, Abdulwahab S, Almodovar E, et al. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J. 2002;23:305-310
74. Kyi Win KM, Chee CB, Shen L, et al. Tuberculosis among foreign-born persons, Singapore, 2000-2009. Emerg Infect Dis. 2011;17:517-519
75. Schaaf HS, Geldenduys A, Gie RP, et al. Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 1998;17:599-604
76. Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J. 1997;16:1108-1112
77. Soeters M, de Vries AM, Kimpen JLL, et al. Clinical features and outcome in children admitted to a TB hospital in the Western Cape - The influence of HIV infection and drug resistance. S Afr Med J. 2005;95:602-606
78. Schaaf HS, Marais BJ, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis. 2007;7:140
79. Schaaf HS, Marais BJ, Hesseling AC, et al. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health. 2009;99:1486-1490
80. Fairlie L, Beylis NC, Reubenson G, et al. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011;11:28
81. del Rosal T, Baquero-Artigao F, García-Miguel MJ, et al. Impact of immigration on pulmonary tuberculosis in Spanish children: a three-decade review. Pediatr Infect Dis J. 2010;29:648-651
82. Marín Royo M, González Morán F, Moreno Muñoz R, et al. Evolution of drug-resistant Mycobacterium tuberculosis in the province of Castellón. 1992-1998. Arch Bronconeumol. 2000;36:551-556
83. Martin-Casabona N, Alcaide F, Coll P, et al. Drug resistance of Mycobacterium tuberculosis. Medicina Clinica. 2000;115 Spain Multicenter study in Barcelona:493-498
84. Mejuto B, Tunez V, del Molino MLP, et al. Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996-2006). Risk Manag Healthc Policy. 2010;3:21-26
85. Borrell S, Español M, Orcau A, et al. Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona. Clin Microbiol Infect. 2010;16:568-574
86. Nejat S, Buxbaum C, Eriksson M, et al. Pediatric tuberculosis in Stockholm: a mirror to the world. Pediatr Infect Dis J. 2011;31:224-227
87. Lin YS, Huang YC, Chang LY, et al. Clinical characteristics of tuberculosis in children in the north of Taiwan. J Microbiol Immunol Infect. 2005;38:41-46
88. Liu CE, Chen C-, Hsiao JH, et al. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. J Microbiol Immunol Infect. 2004;37:295-300
89. Yoshiyama T, Supawitkul S, Kunyanone N, et al. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Int J Tuberc Lung Dis. 2001;5:32-39
90. Dilber E, Göçmen A, Kiper N, et al. Drug-resistant tuberculosis in Turkish children. Turk J Pediatr. 2000;42:145-147
91. Kisa O, Albay A, Baylan O, et al. Drug resistance in Mycobacterium tuberculosis: a retrospective study from a 2000-bed teaching hospital in Ankara, Turkey. Int J Antimicrob Agents. 2003;22:456-457
92. Cox HS, Orozco JD, Male R, et al. Multidrug-resistant tuberculosis in central Asia. Emerging Infect Dis. 2004;10:865-872
93. Djuretic T, Herbert J, Drobniewski F, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax. 2002;57:477-482
94. Story A, Murad S, Roberts W, et al.London Tuberculosis Nurses Network. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62:667-671
95. Teo SS, Riordan A, Alfaham M, et al.British Paediatric Surveillance Unit Childhood Tuberculosis Study Group. Tuberculosis in the United Kingdom and Republic of Ireland. Arch Dis Child. 2009;94:263-267
96. East African and British Medical Research Council. Tuberculosis in Tanzania: a national sampling survey of drug resistance and other factors. Tubercle. 1975;56:269-294
97. Steiner M, Cosio A. Primary tuberculosis in children. 1. Incidence of primary drug-resistant disease in 332 children observed between the years 1961 and 1964 at the Kings County Medical Center of Brooklyn. N Engl J Med. 1966;274:755-759
98. Steiner M, Steiner P, Schmidt H. Primary drug-resistant tuberculosis in children. A continuing study of the incidence of disease caused by primarily drug-resistant organisms in children observed between the years 1965 and 1968 at the Kings County Medical Center of Brooklyn. Am Rev Respir Dis. 1970;102:75-82
99. Steiner P, Rao M, Goldberg R, et al. Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn. Am Rev Respir Dis. 1974;110:98-100
100. Steiner P, Rao M, Victoria MS, et al. A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961 and 1980. Am Rev Respir Dis. 1983;128:425-428
101. Steiner P, Rao M, Mitchell M, et al. Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin. Am Rev Respir Dis. 1986;134:446-448
102. Nolan CM, Aitken ML, Elarth AM, et al. Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis. 1986;133:431-436
103. Khouri YF, Mastrucci MT, Hutto C, et al. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 1992;11:950-955
104. Bakshi SS, Alvarez D, Hilfer CL, et al. Tuberculosis in human immunodeficiency virus-infected children. A family infection. Am J Dis Child. 1993;147:320-324
105. Nelson LJ, Schneider E, Wells CD, et al. Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance. Pediatrics. 2004;114:333-341
106. Al-Akhali A, Ohkado A, Fujiki A, et al. Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004. Int J Tuberc Lung Dis. 2007;11:1328-1333
107. Reubenson G. Pediatric drug-resistant tuberculosis: a global perspective. Paediatr Drugs. 2011;13:349-55
108. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367:348-361
109. Marais BJ, Pai M. Specimen collection methods in the diagnosis of childhood tuberculosis. Indian J Med Microbiol. 2006;24:249-251
110. Seung KJ, Gelmanova IE, Peremitin GG, et al. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis. 2004;39:1321-1328
111. Burugina Nagaraja S, Satyanarayana S, Chadha SS, et al. How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India? PLoS ONE. 2011;6:e25698
112. Steiner P, Rao M, Victoria M, et al. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972. Am Rev Respir Dis. 1974;110:306-311
113. Seddon JA, Visser DH, Bartens M, et al. Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J. 2012;31:711-716
114. Rapid Advice: Treatment of Tuberculosis in Children. 2010 Geneva World Health Organization
115. Starke JR. Tuberculosis of the central nervous system in children. Semin Pediatr Neurol. 1999;6:318-331
116. Lincoln EM. Tuberculous meningitis in children; with special reference to serous meningitis; serous tuberculous meningitis. Am Rev Tuberc. 1947;56:95-109
117. Vinnard C, Winston CA, Wileyto EP, et al. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ. 2010;341:c4451
118. Polesky A, Farber HW, Gottlieb DJ, et al. Rifampin preventive therapy for tuberculosis in Boston’s homeless. Am J Respir Crit Care Med. 1996;154:1473-1477
119. Villarino ME, Ridzon R, Weismuller PC, et al. Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Respir Crit Care Med. 1997;155:1735-1738
120. Schaaf HS, Gie RP, Kennedy M, et al. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics. 2002;109:765-771
121. Fraser A, Paul M, Attamna A, et al. Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review. Int J Tuberc Lung Dis. 2006;10:19-23
122. van der Werf MJ, Langendam MW, Sandgren A, et al. Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews. Int J Tuberc Lung Dis. 2012;16:288-296
123. Cohen T, Colijn C, Wright A, et al. Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med. 2008;177:1302-1306